SAREPTA THERAPEUTICS, INC. Stock Issued During Period, Shares, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- SAREPTA THERAPEUTICS, INC. stock issued during period, shares, new issues for the quarter ending 2013-12-31 was 0.00 shares.
- SAREPTA THERAPEUTICS, INC. stock issued during period, shares, new issues for fiscal 2013 was 3.40M shares, a 30.61% decline from fiscal 2012.
- SAREPTA THERAPEUTICS, INC. stock issued during period, shares, new issues for fiscal 2012 was 4.90M shares.
| Period end | Stock Issued During Period, Shares, New Issues 3 month | Stock Issued During Period, Shares, New Issues 12 month |
|---|---|---|
| 2013-12-31 | 0.00 shares derived: 10-K 12 month − 10-K 9 month · filed 2014-03-03 | 3.40M shares 10-K · filed 2014-03-03 |
| 2012-12-31 | 4.90M shares 10-K · filed 2015-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |